GSK initiates voluntary open offer to increase stake in its pharmaceuticals subsidiary in India

GlaxoSmithKline (GSK) (LSE: GSK) today announced a Voluntary Open Offer (the “Offer”) to increase its stake in its publicly-listed pharmaceuticals subsidiary in India.
Source: GSK news - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals